#hiv-prevention

#hiv-prevention

The Supreme Court case could impact private businesses' obligation to cover HIV prevention medication under the Affordable Care Act.

Supreme Court's Trump-appointed justices may support preserving free preventive health care services against legal challenges.

The Biden administration proposed a new rule mandating insurers to provide injectable PrEP drugs without cost-sharing to increase HIV prevention access.

The new HIV prevention treatment, lenacapavir injection, showed 100% efficacy in early trials, offering an alternative to daily pills like Truvada for prevention efforts.

Injectable cabotegravir offers a new option in HIV prevention and treatment.

Lenacapavir, a new injectable PrEP, shows promising effectiveness in trials, particularly for populations previously underserved by existing medications.

Australian Greens MP Stephen Bates uses OnlyFans to promote free PrEP and engage voters in creative ways.

Mass layoffs at the HHS threaten HIV and STI prevention efforts, especially impacting vulnerable communities.

RFK Jr. plans significant cuts to HIV/AIDS offices and promotes conspiracy theories about AIDS origins.

Dr. Daskalakis is a key figure in HIV prevention and public health advocacy, especially within the LGBTQ+ community.

Lenacapavir, a twice-yearly injectable, is shown to be more effective than Truvada in preventing HIV in recent clinical trials.

Voluntary medical male circumcision significantly reduces HIV transmission risks and is supported by public health experts as a cost-effective intervention.

Lenacapavir shows 100% efficacy in preventing HIV infections in women with simple administration.

It is not a vaccine but highly effective, sparking enthusiasm in the fight against HIV.

The Trump administration plans to eliminate all federal funding for domestic HIV prevention programs, risking progress made in combating the epidemic.

Condom use is vital for HIV prevention among truck drivers frequented by transgender sex workers.

Trump's remarks about Lesotho highlight a lack of awareness regarding U.S. humanitarian aid impacts, particularly on HIV prevention efforts in the country.

Twice-yearly shots for AIDS were 100 percent effective in preventing infections in women, with high potential for broader use as a preventative measure.

Gilead has agreed to make lenacapavir available cheaply in 120 countries, but many high-HIV burden nations are excluded, creating access issues.

Gilead's lenacapavir shows exceptional efficacy in preventing HIV and is a potential game-changer in the global fight against AIDS.

Injections of lenacapavir prevented HIV infection among women in Africa.

Lenacapavir, a new drug, could revolutionize HIV prevention if available affordably globally, priced at $40 a year instead of $42,250 currently.